David Henry is a practising UK barrister, whose practice focuses on European competition law, including merger control, cartels and abuse of dominance, and the interaction between antitrust and intellectual property. He represents companies and trade associations in the aluminium, air transport, car parts, chemicals, electronics, medical devices, pharmaceuticals, power generation, food retailing and financial services and payment systems sectors. He also advises clients in proceedings before the European courts and national competition authorities. David also has considerable experience in export control matters, dispute resolution and white-collar crime.
David has spoken and written extensively on competition law. In recognition of his writing on competition matters, LexisNexis has included David in its Lexis®PSL Competition Expert Lawyers Group. The European courts have also cited his written work. David will be co-editor with Jacques Buhart of the 5th edition of Leniency Regimes.
David is a lecturer on the course entitled Advanced European Competition Law at the University of Liège, Belgium. He has also worked at the European Parliament in Brussels. He completed a pupillage at a “magic circle” set of commercial chambers in London. Before joining the Firm, David worked as an associate at another leading international competition law practice in Brussels.
Education
Inns of Court School of Law, London, BVC, 2006
College of Europe, Bruges, LLM, 2003
King’s College London, LLB, 2002
Ruprecht-Karls-Universität, Heidelberg, German/EU Law, 2001
Fettes College in Edinburgh, 1998
Admissions
England and Wales
Brussels E-list
Courts / Agencies
Courts of England and Wales
Languages
Dutch
English
French
German
Spanish
Counsel | Brussels
Brussels: +32 2 282 35 69
Brussels: +32 2 230 57 13
March 2019
18. Februar 2019
September 26, 2018
August 2018
May 2018
April 24, 2018
March 28, 2018
March 2018
April 2017
International News: Focus On Competition - April 2017
July 2016
January 20, 2016
International News: Focus on Tax - Winter 2015
McDermott International Legal Highlights - August 2015
IP Update, Vol. 18, No. 8 - August 2015
1
2
3
4
January 9, 2018
December 21, 2017
December 20, 2017
March 28, 2017
March 22, 2017
November 18, 2015
November 17, 2015
Pierre Fabre and Array BioPharma Announce Collaboration in Oncology
September 10, 2015
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.
We use cookies to improve the functionality and performance of this site. By continuing to use this site, you are providing us with your consent to our use of cookies. Please see our Privacy Policy for details.
